Mini-resectoscope vs morcellator for in-office hysteroscopic myomectomy: Evaluation of results and patient satisfaction

Eur J Obstet Gynecol Reprod Biol. 2022 Mar:270:95-99. doi: 10.1016/j.ejogrb.2021.12.039. Epub 2022 Jan 5.

Abstract

Introduction: The development of hysteroscopic techniques has led to an advance in submucous myoma treatment, offering a safe and effective minimally invasive alternative. Our objective was to compare the results of hysteroscopic myomectomy when using whether the mini-resectoscope or the MyoSure morcellator, as well as patient satisfaction after the procedure.

Material and methods: A prospective, cross-sectional, observational study including 80 patients distributed into two groups: Mini-Resectoscope group (MRG) or MyoSure group (MSG), depending on the instrument used for the in-office hysteroscopic myomectomy. Resection time, pain during entry, pain during resection, number of resections required, complete resection, and total satisfaction were recorded.

Results: MSG had statistically significant shorter time of entrance. There were no other statistically significant differences between groups.

Conclusions: In-office hysteroscopic myomectomy is associated with high levels of patient satisfaction, without differences between the mini-resectoscope or the MyoSure, allowing high rates of complete resection using both instruments. Thus, it is a feasible technique which could be performed with both instruments, depending on the operator's expertise.

Keywords: Cervical block; Hysteroscopic myomectomy; Hysteroscopic tissue removal system; Hysteroscopy in office; Mini-resectoscope; Myosure.

Publication types

  • Observational Study

MeSH terms

  • Cross-Sectional Studies
  • Female
  • Humans
  • Hysteroscopy / methods
  • Leiomyoma* / complications
  • Leiomyoma* / surgery
  • Patient Satisfaction
  • Pregnancy
  • Prospective Studies
  • Uterine Myomectomy* / methods
  • Uterine Neoplasms* / complications
  • Uterine Neoplasms* / surgery